Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad Tang

Showing results (11-20 of 220) with videos related to

Pageof 22
Sort By:
Cell Cycle (Georgetown, Tex.)|March 14, 2014
MET in ovarian cancer: metastasis and resistance?Chad Tang, Denis L Jardim, David Hong
JAMA Oncology|January 13, 2018
Efficacy and Toxic Effects of Cancer Immunotherapy Combinations-A Double-edged SwordChad Tang, Wen Jiang, Timothy A Yap
Oncoimmunology|May 8, 2015
Author's view: radiation and immunotherapy as systemic therapy for solid tumorsSteven N Seyedin, Chad Tang, James W Welsh
JAMA Oncology|September 14, 2023
Metastases-Targeting Radiotherapy and ADT-ReplyAlexander D Sherry, Paul G Corn, Chad Tang
International Journal of Radiation Oncology, Biology, Physics|April 18, 2026
Setting the TRAP for Oligoprogressive Prostate Cancer: The Impetus for Prospective EvidenceAlexander D Sherry, Ethan B Ludmir, Chad Tang
Bioconjugate Chemistry|February 5, 2009
Design and synthesis of biomimetic hydrogel scaffolds with controlled organization of cyclic RGD peptidesJunmin Zhu, Chad Tang, Kandice Kottke-Marchant, et al.
Advances in Radiation Oncology|October 30, 2018
Toxicity of radiation and immunotherapy combinationsVivek Verma, Taylor R Cushman, Chad Tang, et al.
Stem Cells (Dayton, Ohio)|July 7, 2011
Locally applied vascular endothelial growth factor A increases the osteogenic healing capacity of human adipose-derived stem cells by promoting osteogenic and endothelial differentiationBjörn Behr, Chad Tang, Günter Germann, et al.
Nature Reviews. Clinical Oncology|October 26, 2018
State-of-the-art strategies for targeting the DNA damage response in cancerPatrick G Pilié, Chad Tang, Gordon B Mills, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2025
Reply to: Revisiting Radium-223 in Oligometastatic Castration-Sensitive Prostate Cancer: RAVENS Trial InsightsPhuoc T Tran, Jarey H Wang, Chad Tang, et al.
Pageof 22

Showing results (11-20 of 220) with videos related to

Sort By:
Pageof 22
Cell Cycle (Georgetown, Tex.)|March 14, 2014
MET in ovarian cancer: metastasis and resistance?Chad Tang, Denis L Jardim, David Hong
JAMA Oncology|January 13, 2018
Efficacy and Toxic Effects of Cancer Immunotherapy Combinations-A Double-edged SwordChad Tang, Wen Jiang, Timothy A Yap
Oncoimmunology|May 8, 2015
Author's view: radiation and immunotherapy as systemic therapy for solid tumorsSteven N Seyedin, Chad Tang, James W Welsh
JAMA Oncology|September 14, 2023
Metastases-Targeting Radiotherapy and ADT-ReplyAlexander D Sherry, Paul G Corn, Chad Tang
International Journal of Radiation Oncology, Biology, Physics|April 18, 2026
Setting the TRAP for Oligoprogressive Prostate Cancer: The Impetus for Prospective EvidenceAlexander D Sherry, Ethan B Ludmir, Chad Tang
Bioconjugate Chemistry|February 5, 2009
Design and synthesis of biomimetic hydrogel scaffolds with controlled organization of cyclic RGD peptidesJunmin Zhu, Chad Tang, Kandice Kottke-Marchant, et al.
Advances in Radiation Oncology|October 30, 2018
Toxicity of radiation and immunotherapy combinationsVivek Verma, Taylor R Cushman, Chad Tang, et al.
Stem Cells (Dayton, Ohio)|July 7, 2011
Locally applied vascular endothelial growth factor A increases the osteogenic healing capacity of human adipose-derived stem cells by promoting osteogenic and endothelial differentiationBjörn Behr, Chad Tang, Günter Germann, et al.
Nature Reviews. Clinical Oncology|October 26, 2018
State-of-the-art strategies for targeting the DNA damage response in cancerPatrick G Pilié, Chad Tang, Gordon B Mills, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2025
Reply to: Revisiting Radium-223 in Oligometastatic Castration-Sensitive Prostate Cancer: RAVENS Trial InsightsPhuoc T Tran, Jarey H Wang, Chad Tang, et al.
Pageof 22